• +33 (0)1 48 63 88 63
  • WHO ARE WE ?

    CERAVER, A PIONEER IN ORTHOPAEDICS

    CERAVER, a former subsidiary of the Alcatel-Alsthom group, began its activity in orthopaedics thanks to the chance meeting of a materials engineer, Daniel BLANQUAERT, and an orthopaedic surgeon, Pierre BOUTIN. This meeting marked the start of a series of innovations that would revolutionise the world of hip replacement orthopaedics.

    This is how the invention of the alumina-alumina articulation total hip prosthesis came about, along with discovering the significant potential of titanium alloy TiAl6V4.

    CERAVER, AN INNOVATIVE COMPANY

    From alumina to anti-bacterial adhesion coating

    « Ambitious and modest, we are involved in the continuous improvement of the treatment of pathologies of the musculoskeletal system with determination and common sense.

    Above all, we rely on close collaboration with a number of renowned surgical and scientific teams, on our experience, on our energy and on the commitment of all our collaborators in a particularly multidisciplinary field. »

    Daniel BLANQUAERT

    Daniel BLANQUAERT

    CERAVER CEO

    Your patient, our priority

    Since its fundation, CERAVER is a company aiming for excellence, placing patient’s well-being at its center. Supported by renowned surgeons sharing our values, our approach is based on 5 axes which are the key words of our development strategy.

    Ceraver - Our patients

    Ethics and code of conduct

    Our approach is based on a strict respect about:

    • Obligations in terms of ANTI-GIFT LAW (Art.L4113-6 of the CSP and Order of January 19, 2017)

    • TRANSPARENCY (Art.L1453-1 of the CSP and Decree of December 28, 2016)

    • Compliance with the principle of acceptability of Benefit/Risk for the patient

    A French expert in orthopaedics

    ceraver contact

    Based next to Paris, CERAVER has always been concerned to maintain all of its industrial activities in France. Thanks to that, design, industrial expertise, production and accreditation are all performed in France, thus respecting the regulatory requirements applied in Europe. Two production facilities totalling over 10,000m2 where last production and control technologies are implemented, ensure pursuit of excellence.

    Mastery from design to manufacturing

    CERAVER is the designer and manufacturer of its prostheses and associated surgical instruments. Pioneer and initiator of the use of alumina in orthopaedics, CERAVER is one of the only actors of this market to control the finishing of alumina ceramic.

    This know-how and experience allow us to control the quality of our products and processes, to benefit from an optimal response time and to be totally independent.

    Strict quality control and traceability

    An implantable product must be of impeccable quality. This is why CERAVER’s quality system is regularly examined and certified by an independent organization according to the ISO 13485 standard.

    A traceability is ensured from the primary material to the finished product allowing to follow a product during all its lifecycle (batches of primary materials, controls, results, control machines, controller, surgeon, date and place of implantation)

    CERAVER'S INNOVATIONS IN FEW DATES

    loading
    • 1969

      Biology, tribology

      Biology, tribology

      January 1, 1969
      First tests on Al2O3 – Al2O3  articulation : Biology, tribology.
    • 1970

      Dr Pierre Boutin

      Dr Pierre Boutin

      January 1, 1970
      Dr Pierre Boutin performed the world’s first total hip prosthesis with an alumina-alumina articulation. This component presents very low wear and friction characteristics – essential parameters in the design of joint prostheses. Perfectly biotolerant, this component went on to become the reference for articulations.
    • 1971

      Titanium TiAl6V4

      Titanium TiAl6V4

      January 1, 1971
      Discovery of the potential of the titanium alloy TiAl6V4 by Daniel Blanquaert. Dr Pierre Boutin performed the world’s first implantation of a hip with a femoral stem made of titanium alloy TiAl6V4. This material went on to become the reference and is universally used in orthopaedics.
    • 1982

      World’s first implant

      World’s first implant

      January 1, 1982
      World’s first implant
      World’s first implant of a cement-free metal cup in titanium alloy for a hip prosthesis with an alumina ceramic core, a solution subsequently adopted by all the world’s major laboratories.
    • 1986

      HERMES 2C

      HERMES 2C

      January 1, 1986
      First implantation of our 2C HERMES, a total knee prosthesis which both cruciates remain intact.
    • 1989

      TRIRADIUS

      TRIRADIUS

      January 1, 1989
      First implantation of our CERAFIT metal cup using the “triradius” concept.
    • 1990

      Posterior stabilized HERMES

      Posterior stabilized HERMES

      January 1, 1990
      First implantation of our posterior stabilized knee prosthesis, HERMES PS.
    • 1997

      Patellofemoral HERMES

      Patellofemoral HERMES

      January 1, 1997
      HERMES Patellofemoral first implantation.
    • 2011

      CERADISC

      CERADISC

      January 1, 2011
      Europeen patent for our cervical disc prosthesis, CERADISC.
    • 2016

      ACTISURF

      ACTISURF

      January 1, 2016
      ANSM authorization for clinical studies on the ACTISURF bacterial anti-adhesion coating.
    • 2020

      Biology, tribology

      Biology, tribology

      November 9, 2020
      Biology, tribology
      First tests on Al2O3 – Al2O3  articulation : Biology, tribology.